After his Cancer Moonshot work, Vice President Joe Biden plans to head up a new nonprofit that will work on cancer issues—including high drug prices.

Greek prosecutors have raided Novartis offices and questioned 178 people in a bribery investigation launched after corruption allegations surfaced in local…

The FDA’s promotional enforcement squad wasn’t very active in 2016—until December, that is. This month, they've cited six drugmakers, more than half the…

We won’t surprise anyone by saying that Topic No. 1 in pharma this year was drug pricing. We’ll give you one guess as to whether 2017 will be more of the same…

CMS has backed off a new payment model for Medicare Part B, saying it would not finalize the proposed model during President Obama’s administration.

Officials in the U.K. are taking issue with huge price hikes, now targeting Actavis for a 12,000% increase.

Seven years after safety concerns altered the trajectory of Pfizer’s stop-smoking med Chantix, the FDA has pulled its black-box warning from the drug’s label.

Twenty states have unveiled a civil lawsuit accusing half a dozen drugmakers, including Mylan, Teva and Heritage, with generic drug price fixing just a day…

The FDA Wednesday approved an eczema treatment developed by Anacor, which Pfizer bought in June, that is projected to be a $2 billion blockbuster.

Regulatory